by Jordana Choucair | Jan 4, 2023 | M&A
The Oregon Health Authority (OHA) approved Amazon’s proposed acquisition of One Medical after conducting a regulatory review. The regulator concluded the acquisition would be unlikely to affect access and cost for Oregonians and ruled out a more comprehensive review...
by Jordana Choucair | Dec 16, 2022 | M&A
Two New Jersey-based health systems – Cape Regional Health System and Cooper University Health – signed a letter of intent to merge into a system of more than 10,000 employees and over $2.2 billion in annual revenues. Cooper University Health is the major academic...
by Jordana Choucair | Dec 12, 2022 | M&A
Amgen Inc. has agreed to buy biotechnology company Horizon Therapeutics PLC in a deal worth $27.8 billion, the largest health care acquisition of the year. The all-cash deal is equal to a nearly 20 percent premium over Horizon’s closing stock price on Friday....
by Jordana Choucair | Dec 8, 2022 | M&A
LHC Group and UnitedHealth Group disclosed to the Securities and Exchange Commission that their $5.4 billion proposed merger won’t consummate as planned by the end year. According to the filing, the agreement was extended until March 28, 2023 as the two...
by Jordana Choucair | Nov 30, 2022 | M&A
Horizon Therapeutics PLC is hearing buyout offers from pharmaceutical companies Amgen Inc., Johnson & Johnson’s Janssen Global Services LLC, and Sanofi. Horizon, which makes medicines for rare and immune diseases, had a market value of $18 billion as of...
by Jordana Choucair | Nov 29, 2022 | M&A
AstraZeneca PLC announced it will acquire Neogene Therapeutics Inc. in a deal worth up to $320 million, growing the company’s oncology portfolio. The transaction is expected to close in the first quarter of 2023, subject to customary closing conditions and...
Recent Comments